The main lesson being learned from the COVID-19 pandemic is the importance of detecting cases early, following up on close contacts and preventing further disease spread for as long as possible. Other new and emerging diseases can affect us anywhere and at any time.
The European Centre for Disease Prevention and Control, the World Health Organization Regional Office for Europe, and the European surveillance networks for COVID-19 and influenza agree on the urgent need to develop and sustain resilient population based integrated surveillance systems for influenza, COVID-19, and potentially other respiratory virus infections (such as RSV or new viral diseases of public health concern). However, it can’t be limited to just these infectious diseases.
The next generation of surveillance tools and technologies needs to be inexpensive, non-invasive, and digitally reportable to increase the chances of a truly global adoption.
As we transition to a new standalone life sciences and diagnostics company under a new brand, we will continue to work together with international health and scientific communities, governments, and corporations, committed to supporting the building of a new pandemic response and containment model that delivers resilience and strength for the future of global health.